Intravenous Lormetazepam during Sedation Weaning in a 26-Year-Old Critically Ill Woman
Recent evidence revealed that sedation is related to adverse outcomes including a higher mortality. Despite this fact, patients sometimes require deep sedation for a limited period of time to control, for example, intracranial hypertension. In particular in these cases, weaning from sedation is ofte...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2014-01-01
|
| Series: | Case Reports in Critical Care |
| Online Access: | http://dx.doi.org/10.1155/2014/372740 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832564688029745152 |
|---|---|
| author | Alawi Luetz Bjoern Weiss Claudia D. Spies |
| author_facet | Alawi Luetz Bjoern Weiss Claudia D. Spies |
| author_sort | Alawi Luetz |
| collection | DOAJ |
| description | Recent evidence revealed that sedation is related to adverse outcomes including a higher mortality. Despite this fact, patients sometimes require deep sedation for a limited period of time to control, for example, intracranial hypertension. In particular in these cases, weaning from sedation is often challenging due to emerging agitation, stress, and delirium. The submitted research letter reports a rare case of severe and persisting agitation that was unresponsive to all available treatments. Ultimately, lormetazepam which has recently become available for intravenous use in Germany resolved the problem by stress-reduction and anxiolysis without leading to measurable sedation. |
| format | Article |
| id | doaj-art-66d0765979674692b787abc3079b8c27 |
| institution | Kabale University |
| issn | 2090-6420 2090-6439 |
| language | English |
| publishDate | 2014-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Critical Care |
| spelling | doaj-art-66d0765979674692b787abc3079b8c272025-02-03T01:10:28ZengWileyCase Reports in Critical Care2090-64202090-64392014-01-01201410.1155/2014/372740372740Intravenous Lormetazepam during Sedation Weaning in a 26-Year-Old Critically Ill WomanAlawi Luetz0Bjoern Weiss1Claudia D. Spies2Department of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Campus Charité Mitte and Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Campus Charité Mitte and Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, GermanyDepartment of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Campus Charité Mitte and Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin, GermanyRecent evidence revealed that sedation is related to adverse outcomes including a higher mortality. Despite this fact, patients sometimes require deep sedation for a limited period of time to control, for example, intracranial hypertension. In particular in these cases, weaning from sedation is often challenging due to emerging agitation, stress, and delirium. The submitted research letter reports a rare case of severe and persisting agitation that was unresponsive to all available treatments. Ultimately, lormetazepam which has recently become available for intravenous use in Germany resolved the problem by stress-reduction and anxiolysis without leading to measurable sedation.http://dx.doi.org/10.1155/2014/372740 |
| spellingShingle | Alawi Luetz Bjoern Weiss Claudia D. Spies Intravenous Lormetazepam during Sedation Weaning in a 26-Year-Old Critically Ill Woman Case Reports in Critical Care |
| title | Intravenous Lormetazepam during Sedation Weaning in a 26-Year-Old Critically Ill Woman |
| title_full | Intravenous Lormetazepam during Sedation Weaning in a 26-Year-Old Critically Ill Woman |
| title_fullStr | Intravenous Lormetazepam during Sedation Weaning in a 26-Year-Old Critically Ill Woman |
| title_full_unstemmed | Intravenous Lormetazepam during Sedation Weaning in a 26-Year-Old Critically Ill Woman |
| title_short | Intravenous Lormetazepam during Sedation Weaning in a 26-Year-Old Critically Ill Woman |
| title_sort | intravenous lormetazepam during sedation weaning in a 26 year old critically ill woman |
| url | http://dx.doi.org/10.1155/2014/372740 |
| work_keys_str_mv | AT alawiluetz intravenouslormetazepamduringsedationweaningina26yearoldcriticallyillwoman AT bjoernweiss intravenouslormetazepamduringsedationweaningina26yearoldcriticallyillwoman AT claudiadspies intravenouslormetazepamduringsedationweaningina26yearoldcriticallyillwoman |